T细胞特征对血液性恶性瘤中CAR-T细胞疗法的影响
Zhongfei Tao1,2, Zuzana Chyra1,2, Jana Kotulová1,2
1Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
Blood cancer journal
|December 3, 2024
概括
卡尔-T细胞疗法对血液癌症有希望,但由于瘤细胞杀死不足,通常会失败. 了解T细胞特征,如疲劳和记忆,是改善CAR T细胞有效性和患者治疗结果的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法已经改变了血液恶性瘤治疗.
- 然而,很大一部分患者无法长期控制瘤.
- 这种限制部分归因于CAR-T细胞的瘤根除能力不足.
研究的目的:
- 审查当前关于影响CAR T细胞治疗疗效的内在T细胞特征的研究.
- 提供对影响CAR T细胞功能的生物学因素的全面了解.
- 为了指导CAR T细胞应用的改进,以提高有效性和安全性.
主要方法:
- 关于T细胞生物学和CAR T细胞治疗的研究进展的文献综述.
- 对影响CAR T细胞有效性的T细胞内在特征的分析.
- 综合有关T细胞耗尽,记忆子集,衰老,调节性T细胞,CD4+/CD8+比率,新陈代谢和T细胞受体谱的信息.
主要成果:
- 多种内在T细胞特征显著影响CAR T细胞治疗结果.
- 关键因素包括T细胞耗尽,记忆子集,衰老,调节性T细胞,CD4+/CD8+比率,新陈代谢和T细胞受体谱.
- 了解这些因素对于改善CAR T细胞功效至关重要.
结论:
- 对T细胞生物学的全面洞察力可以改进CAR T细胞治疗应用.
- 提高对T细胞特征的理解将提高疗效和安全性.
- 这种知识对于推进血液性恶性瘤患者的CAR T细胞治疗至关重要.
相关概念视频
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
T Cell Activation and Clonal Selection
658
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
658
T Cell Types and Functions
951
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
951
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Cell-mediated Immune Responses
67.0K
Overview
67.0K
Cytotoxic T Cells-mediated Immune Response
846
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
846


